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Forty-six patients who had coronary artery disease, left 
ventricular aneurysm and life-threatening ventricular tachy- 
arrhythmia underwent surgical treatment to eliminate or 
facilitate control of the arrhythmia. Surgery was performed 
without the assistance of intraoperative mapping tech- 
niques. Forty-three patients underwent preoperative or 
postoperative electrophysiologic testing, or both, and anti- 
arrhythmic therapy was added, when indicated, postoper- 
atively. The patients had a mean age of 63 years, a mean 
preoperative left ventricular ejection fraction of 27 + 9% 
and a mean preoperative left ventricular end-diastolic 
pressure of 23 f 9 mm Hg. Twenty-one patients (46%) 
underwent surgical treatment within 2 months of their last 
myocardial infarction. 
The overall operative mortality rate was 6.5% (three 
patients). Eighteen of the 43 operative survivors were 
discharged from the hospital on no antiarrhythmic therapy, 
Since the original description by Couch (1) of left ventricular 
aneurysmectomy for control of ventricular tachycardia, sur- 
gical procedures have become an important form of treat- 
ment for life-threatening ventricular arrhythmias in patients 
who have coronary artery disease. Initially, the success rate 
in abolishing recurrence of ventricular tachycardia with a 
“blind” aneurysm resection was low (2.3). Since then, a 
number of other operative techniques have been developed. 
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whereas 25 received additional antiarrhythmic treatment. 
During a mean follow-up period of 36 months (range 2 to 
88), there were 13 deaths; eight patients died suddenly, 
three died of congestive heart failure, one of myocardial 
reinfarction and one from a noncardiac cause. The overall 
cumulative cardiac mortality rate at 1, 2 and 3 years was 
16, 22 and 35%, respectively, whereas the sudden cardiac 
death rate was 5, 12 and 20%, respectively. 
This experience suggests that high risk patients who 
undergo nonguided surgery for life-threatening ventricular 
arrhythmia and left ventricular aneurysm have a relatively 
low surgical mortality and a better long-term survival than 
previously reported. However, if utilized, such an approach 
must be systematically supported by perioperative elec- 
trophysiologic testing to determine the need for supplemen- 
tal antiarrhythmic therapy. 
(J Am Co11 Cardiol1989;13:153-62) 
These include. in addition to aneurysmectomy, visually 
directed extensive endocardial resection (4.5). encircling 
endocardial ventriculotomy (6) and intraoperative map- 
guided endocardial resection, cryoablation or laser ablation 
(7-13). The combined use of these techniques has also been 
reported (14-16). 
Since 1980, 46 consecutive patients who had ventricular 
tachyarrhythmia and coronary artery disease have under- 
gone surgical treatment at our institution; the operative 
procedures consisted of a standard ventricular aneurysm 
resection combined with a shallow endocardial encircling 
ventriculotomy, visually directed endocardial resectionicryo- 
ablation and, when indicated, coronary artery bypass graft- 
ing. The operations were unassisted by intraoperative map- 
ping techniques, but supported by preoperative and 
postoperative electrophysiologic testing and, when indi- 
cated, by additional antiarrhythmic therapy. 
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Methods 
Study patients. Between February 1980 and December 
1986,46 consecutive patients who had experienced episodes 
of life-threatening ventricular tachyarrhythmia underwent 
cardiac surgery at our institution in an attempt to eliminate 
or help control these episodes. The clinical, angiographic 
and hemodynamic data of the 46 patients are listed in Table 
1. There were 39 men and 7 women, 44 to 80 years of age 
(mean 63). Twenty-eight patients presented with sustained 
hypotensive ventricular tachycardia, 17 with aborted sudden 
cardiac death and 1 patient with syncope. No patient had an 
arrhythmia that was due to proarrhythmic effects of a drug or 
to other readily reversible causes or that occurred during 
acute myocardial infarction. All but two patients had previ- 
ously required one or more direct current shocks for resto- 
ration of sinus rhythm. 
All patients had coronary artery disease and had sus- 
tained at least one myocardial infarction. All 46 patients had 
a left ventricular aneurysm, which was anterior in 39, 
inferior in 6 and both anterior and inferior in 1. Ten patients 
had a ~50% reduction in the diameter of three coronary 
vessels, 20 had two-vessel disease and 12 had one-vessel 
disease. Two patients had angiographically high grade left 
main coronary artery stenoses and two had minor luminal 
irregularities. The mean left ventricular ejection fraction 
measured angiographically was 27 ? 9% (range 13 to 56), and 
the mean left ventricular end-diastolic pressure was 23 * 9 
mm Hg (range 5 to 44). Two patients required intraaortic 
balloon counterpulsation preoperatively for hemodynamic 
support. 
Before undergoing operative treutment, each patient had 
received two to seven antiarrhythmic drugs (mean 3.8) in an 
attempt to eliminate episodes of spontaneous or induced 
sustained ventricular tachyarrhythmia. Two patients whose 
ventricular tachycardia was controlled with antiarrhythmic 
drugs and who underwent operation for intractable cardio- 
genie shock are not included in this series. Twenty-one 
patients (46%) underwent surgical treatment within 2 months 
of their last myocardial infraction. 
Definitions. The following definitions are used. Sudden 
cardiac death: Unexpected death occurring within 1 h of 
onset of symptoms in an individual otherwise clinically 
stable. 
Aborted sudden cardiac death: Sudden circulatory col- 
lapse, without associated acute myocardial infarction, re- 
sulting in loss of consciousness and vital signs and requiring 
cardiopulmonary resuscitation, including direct current 
shock. 
Ventricular aneurysm: Area of infarcted ventricle with 
loss of trabeculations, producing a distinct dyskinetic bulge 
during systole. 
Nonsustained ventricular tachycardia: Six or more ven- 
tricular complexes self terminating within 30 s. 
Sustained ventricular tachycardia: Ventricular tachycar- 
dia lasting >30 s or requiring earlier termination because of 
hemodynamic deterioration. 
Operative death: Death occurring before the patient’s 
discharge from the hospital, or within 30 days of the time of 
surgery. 
General strategy. After admission to the coronary care 
unit or the telemetry unit, the patients were prepared for 
cardiac catheterization and angiography unless these had 
already been performed elsewhere. Variable amounts of 
time were spent in trying to suppress spontaneous or in- 
duced ventricular tachycardia with antiarrhythmic drugs. 
Whenever possible, preoperative electrophysiologic studies 
were performed with the patient in a drug-free state. If the 
patient had already received multiple unsuccessful anti- 
arrhythmic drug trials, the goal of electrophysiologic testing 
was limited to characterizing the tachyarrhythmia and de- 
fining the mode of induction preoperatively. If a patient 
seemed to have responded to an antiarrhythmic drug, elec- 
trophysiologic testing was used to examine this drug’s ability 
to prevent the induction of ventricular tachyarrhythmia. 
Postoperative electrophysiologic testing was performed in 
most patients before hospital discharge to assess the results 
of surgical intervention. If no ventricular tachyarrhythmia 
was induced, the patient was discharged from the hospital 
receiving no additional antiarrhythmic therapy. If a sponta- 
neous or induced arrhythmia was observed that was consid- 
ered clinically important or equivocal, further therapeutic 
efforts were initiated. 
Electrophysiologic studies. Preoperative electrophysiolo- 
gic studies and programmed stimulation were performed 
with the patient in a nonsedated, postabsorptive state. One 
to three multipolar electrode catheters were inserted percu- 
taneously and advanced under fluoroscopic guidance to the 
high right atrium, His bundle region, right ventricle and, in 
nine cases, to the left ventricle. Programmed ventricular 
stimulation included introduction of single, double and triple 
extrastimuli during sinus rhythm and during paced rhythm at 
cycle lengths of 600, 500 and 400 ms, incremental pacing to 
a rate of 200 beatsimin and bursts of eight beats to the 
shortest cycle length still able to produce 1:l ventricular 
capture. Rectangular pulses of 2 ms duration and twice 
diastolic threshold were delivered from a Bloom DTU-101 
programmable stimulator. In eight cases in which sustained 
ventricular tachycardia manifested sufficient hemodynamic 
stability, left ventricular endocardial mapping was per- 
formed with a 6F Josephson quadripolar electrode catheter. 
Postoperative electrophysiologic testing was performed with 
a single ventricular endocardial catheter and an identical 
stimulation protocol. If left ventricular stimulation was re- 
quired to induce the arrhythmia preoperatively, it was used 
postoperatively. 
Surgical procedure. All procedures were performed 
through a medial sternotomy incision with use of total 
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Table 1. Clinical. Angiographic and Hemodynamic Chardcterisitics of the 46 Patients 
Patient 
Age (yri Clinical 
Gender Presentation 
Number of 
Diseased 
Coronary 
Vessels 
Site of LV LVEF LVEDP No. 01 
Aneurysm (CL) (mm Hg) A.4 Tried 
Time From 
AM1 to 
Surgery 
(mo) 
I 
1 
3 
4 
5 
6 
7 
8 
Y 
IO 
II 
I2 
13 
I4 
I5 
I6 
17 
IX 
19 
20 
11 
21 
23 
24 
2.5 
26 
27 
28 
29 
30 
31 
3’ _-
33 
34 
35 
36 
31 
38 
39 
40 
41 
41 
43 
44 
45 
46 
44/k VT 0 Int 
57:M VI 3 Ant 
67’M ASCD 1 Ant 
74iM VT 3 Ant 
76,‘M ASCD LMCA Ant 
52/M VT I Pint 
6.W VT I Ant 
630 ASCD 2 Ant 
7o:hI ASCD 1 Inf 
Whl ASCD 1 Ant 
45ihl VT 1 Ant 
75,‘hl ASCD 2 Ant 
58/M VT 2 Ant 
67/M VI‘ 1 Ant 
71!hl ASCD I Ant 
60/M ASCD 2 Ant 
62ihI VT LMCA lnf 
57’M ASCD 2 Ant 
64/h] ASCD 3 Ant 
74’hl ASCD I Ant 
73!hl VT 3 Ant 
701hl VT 2 .4nt 
64/l, VI I .4nt 
56ihl ASCD I Ant 
47!hI VT I .4nt 
61ihl ASCD I Ant 
58ihl ASCD 3 Ant 
Whl S)rl I Ant 
6‘Ul vr z Ant 
68ihI VT 1 Inf 
58!hl ASCD ? Ant 
53/hl vr 3 Ant 
60ihl ASCD 0 Ant 
6l.hl V-l I Ant 
40,lhl VT I .Ant 
44:hl VT 3 Inf t Ant 
.x:1: ASCD ? Ant 
63!hl VT ? Ant 
XOlhl VT 2 Ant 
67/l’ VT 3 Inf 
74ihl VT z Ant 
70ihl VT ? Ant 
(Y/h1 VI 3 Ant 
7911. VT 3 Inf 
6Y;hl VT I Ant 
6X’hl VT 3 Ant 
56 5 
31 I6 
I6 ‘I 
25 I5 
IY 24 
I3 3X 
22 X 
26 
40 
22 
IX 
36 
10 
14 
25 
21 
I6 
II 
26 
30 
13 
29 
2X 
24 
IY 
30 
37 
30 
46 
35 
17 
IS 
17 
10 
16 
17 -_ 
.J I 
25 
I5 
38 
25 
.32 
47 
33 
30 
- 
30 
10 
35 
35 
1s 
I6 
I5 
27 
34 
34 
2x 
36 
I6 
17 
1 
20 
- 
17 
27 
IS 
30 
I3 
32 
44 
IX 
I4 
17 
23 
I7 
30 
I? 
I’ ‘. 
30 
I? 
17 
I6 
9 
26 
!I6 
I? 
72 
5 
I20 
I 
I 
2 wk 
3 wk 
72 
I 
1 
I 
2 
24 
I? 
? 
I 
I 
I 
IOX 
6 
60 
I 
I 
I 
I 
60 
7 
7 
? 
4 
100 
I08 
5 
60 
5 
? 
3 wk 
I2 
3 wk 
60 
1x0 
60 
I wk 
7 
AA = <mtiarrhythmic agent: AMI = acute myocardial infarction; Ant = anterior: ASCD = aborted sudden cardiac death: F = female; Inf = inferior: 
LMCA = left main coronary artery; LV = left ventricular: LVEDP = left ventricular end-diastolic pressure; LVEF = left ventricular ejection fraction: M = male: 
Syn = syncope: VT z hypotensive sustained ventricular tachycardia: - = measurement not available, 
cardiopulmonary bypass and moderate systemic hypother- cardial temperature was continuously measured with a ther- 
mia (28 lo 30°C). The aorta was then occluded and cardio- mistor placed in the left ventricular myocardium opposite 
plegia was induced by infusion of a cold (4°C) crystalloid the aneurysm and was maintained at IO to 15°C by repeated 
solution containing 25 mEq/liter of potassium chloride. Myo- infusions of the cardioplegic solution at 20 to 30 min inter- 
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Table 2. Operative Procedures in 46 Patients Table 3. Preoperative Electrophysiologic Study in 33 Patients 
Patient 
Left ventricular aneurysm resection 
Encircling endocardial 
ventriculotomy 
No. % 
46 100 
46 100 
Coronary artery bypass graft 
Subendocardial resection 
AICD leads implanted 
Ventricular septal prophylactic 
patch 
33 72 
20 43 
IS 33 
5 11 
AICD device 3 
Mitral valve replacement 3 
Cryoablation 2 
AICD = automatic implantable cardioverteridefibrillator. 
No. % 
Patients studied 33 72 
Inducible sustained VT 30 
Inducible nonsustained VT 3 
Patients not studied 13 28 
Frequent spontaneous VT IO 
Cardiogenic shock 1 
EPS aborted because of severe angina 1 
Nonmedical reason 1 
Total 46 100 
EPS = electrophysiologic study: other abbreviations as in Table 1. 
Results 
vals. All patients had excision of the component of the 
aneurysm involving the free wall of the left ventricle. An 
encircling endocardial incision 3 to 5 mm in depth at the 
margin between normal appearing myocardium and the 
residual scar was performed in all patients (Table 2). Suben- 
docardial resection of the septum and additional focal areas 
of fibrosis was performed in 20 patients and cryoablation of 
such areas in two patients. Insertion of a Dacron patch to 
stabilize the infarcted septum was performed in five patients. 
Thirty-three patients received coronary artery bypass grafts. 
Three patients required mitral valve replacement because of 
severe preexisting mitral regurgitation (one patient) or ex- 
tensive fibrosis of the posterior papillary muscles adjacent to 
an aneurysm of the inferior wall (two patients). Leads of the 
automatic internal cardioverterldefibrillator (AICD) were 
implanted in I5 patients. One patient had AICD implantation 
at the initial procedure and two patients at a subsequent 
procedure. The mean duration of cardiopulmonary bypass 
was 95 ? 40 min and the duration of aortic clamping was 50 
? 29 min. 
Long-term follow-up. Fourteen patients were regularly 
followed up in our arrhythmia clinic to the end of the study 
period, and 32 patients were returned to their referring 
physicians for long-term care. A functional assessment of 
each surviving patient was performed after complete recov- 
ery from the operation and discharge from the hospital. 
Information regarding patients followed up elsewhere was 
obtained through telephone conversations with the referring 
physicians, the patients themselves or their immediate rela- 
tives. Causes of death were determined from review of 
medical records, autopsy reports, death certificates and 
telephone conversations as described. 
Preoperative electrophysiologic studies. Of 33 patients 
who underwent preoperative electrophysiologic testing, 30 
(91%) had inducible sustained ventricular tachycardia (Ta- 
bles 3 and 4). Nonsustained ventricular tachycardia was 
induced in three patients (9%). These three patients had 
suffered from out-of-hospital cardiac arrest and, during 
electrophysiologic testing, had reproducible, very rapid non- 
sustained ventricular tachycardia that was considered an 
adequate end point of induction. Ten patients were receiving 
antiarrhythmic drugs when undergoing preoperative testing. 
In eight the drugs were administered to slow the rate of 
tachycardia in an attempt to map its site of origin by 
catheter; 2 others, who were transferred to our institution 
receiving amiodarone, had therapeutic plasma concentra- 
tions of this drug. Catheter mapping was successfully com- 
pleted in eight patients, seven of whom were receiving one 
or more antiarrhythmic agents. Preoperative testing of one 
to four antiarrhythmic drugs that had suppressed ventricular 
tachyarrhythmia during in-hospital monitoring was carried 
out in the electrophysiology laboratory in 12 patients. Ven- 
tricular tachycardia was eliminated by intravenous procai- 
namide in a single patient (Patient 2). In 1 I patients, nearly 
all of whom had undergone several unsuccessful drug trials, 
no additional drug testing was performed in the electrophys- 
iology laboratory. 
Data analysis. Kaplan-Meier survival curves were gener- 
ated using the LIFETEST procedure of the Statistical Anal- 
ysis System as implemented on the Washington University 
IBM mainframe computer system. Results are presented as 
mean values -+ SD. 
Thirteen of the 46 patients did not undergo preoperative 
electrophysiologic testing. Of these, 10 continued to mani- 
fest frequent spontaneous episodes of sustained ventricular 
tachycardia despite trials with two to seven antiarrhythmic 
agents, 1 patient underwent emergency surgery for incessant 
ventricular tachycardia complicated by cardiogenic shock 
and in 1, testing was aborted because of severe angina 
associated with marked ST segment depression on the 12 
lead electrocardiogram during and after ventricular pacing. 
Preoperative electrophysiologic testing was not performed in 
one patient for nonmedical reasons. 
Postoperative deaths and complications. There were three 
hospital deaths (6.5%); two patients died of septic compli- 
cations and one had fulminant postoperative amiodarone 
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Table 4. Results of Preoperative and Postoperative Electrophysiology Studies and Follow-Up 
Postoperative EPS 
Pt AA Tried 
Preoperative EPS 
CL 
AI tms) 
Initial Final 
CL Cl 
AI (ms) AA Al tmsi API 
1 L,P.T,D,F.Q.S VT-S 
2 L.P VT-S 
240 
350 
None 
VT-NS 
Long-Term Recurrence of 
Therapy VT 
None 0 
None I, CL 375 m\; 
AI-W 
A + w 
3 L.P.Q.M.A Died (CHF)* 
4 L.P.Q.Ph,B 
5 L.P 
6 L.P.Pt. 
7 L.P.Q 
8 L.P 
9 L.P 
10 L.P 
II L.P.Q 
12 L.B 
A + w 
Died (SCD) 
A + w 
A+W 
A - w 
A - W 
Died (SCD) 
Died (SCD) 
Died (SCD) 
13 L.Q.P 
14 L.P 
A + w 
I5 l.,P 
23 
210 None 27 
suppressed 
with P 
VT-S 440 VT-NS 350 A 4 + AICD 41CD discharge 23 
x I 
VT-S 250 VT-S 250 None None 0 30 
VT-S 200 Refused Q 2 
Not done VF None 0 33 
Not done None None 0 39 
VT-NS 230 VF None AICD (I 34 
VT-S 320 VT-S 300 None VT-S 350 P .4 t AICD 0 31 
VT-NS 200 VT-S 260 None None P P IO 
VT-S 400 VT-S 290 None None P P 34 
Not done Not done None 27 
(postop 
CVA) 
VT-S 230 VT-S 220 None VT-S 420 F F 0 45 
VT-S 400 Not done 
top death) 
VT-S 280. 380 Refused None 0 53 
460 
Not done VT-NS 280 None None Lo t .A Lo t A 0 56 
VT-S 400 Not done Q+A 0 I2 
A + w 
I6 L.P.B. 
I7 L.P.Q.Lo.Ap.A 
(spent VT) 
I8 L,P.Q.B,Ap,Ph VT-S 240 VT-NS 260 None VT-S 280 P 
I9 L,P,B,A VT-S 330 VT-S 300 None None P 
20 L,P.Q.B.A VT-S 430 VT-NS 230 A None PtA 
A +- w 
Died tCHFl 
21 L,P,Q.A VT-S 360 VT-S 360 A None PtAtPh PtAtPh 
22 L,P.Q.B VT-S 350 VT-NS 200 None VT-NS 260 P P 
23 L.P,Q.D VT-S 290 None None 
24 L.P,Q.Ap,B,M.A Not done Refused None 
25 L.P.Q.B Not done Not done 
top death) 
26 L,P.Q.M,Ap. Ph Not done VT-S 280 None None QtAtPh QtAtPh 
PtA 
PtA 
PtA 
Died (SCDl 24 
0 AtW 59 
0 Died (CHF) 34 
0 .4 + w 56 
0 Died (AMI) 25 
Died (SCD) 61 
0 A + w 78 
27 L.P.Q.D.Ph.Ap 
28 L.P,Q.Ap 
29 L,Q,Ph.B 
30 L.P,M.Ap 
31 L.P,Q.Ph 
32 L.P.Q.D.Ph 
33 L.P.Ph 
34 L.P,D 
35 L.Q.B 
36 L,P,Q.B,F.A 
37 L.Q.A 
Died (CHF) 
A t w 
A+W 
Died tCVAl 
A t w 
A + w 
Died (SCD) 
A + w 
A L w 
A + w 
.4 t w 
38 L.P.F,B 
39 L.Q.A 
40 L.Q.M.A 
41 L.P.Ph.A 
42 L.P.E.S 
43 L.l 
44 L,Q.Ph 
45 L.P.B 
46 P.Q.M.A 
0 8 
Not done VT-NS 270 None None u a 0 78 
VT-S 250 VT-NS 190 None None P P 0 73 
VT-S 400 None None 0 I2 
VT-S 310 VT-S 360 None VT-S 490 Lo 
gPh 
0 80 
VT-S 200 VT-NS None None Q.Ph 0 88 
Not done None None - 42 
VT-NS 240 None None 0 80 
VT-S 330 None None 0 82 
VT-S 310 VT-NS 310 None None Q Q 0 79 
VT-S 240 None A 0 I6 
VT-S 200 Not done 
(op death) 
VT-S 200 None 0 20 
Not done None A .4 0 15 
VT-S 380 VT-S 380 None VT-NS 350 P P 0 13 
Not done None None 0 9 
VT-S 260 VT-S 230 None 0 9 
Not done VT-S 260 VTS 500 A+F .4 t F 0 8 
Not done None None 0 7 
VT-S 250 None None 0 7 
VT-S 380 None A A 0 6 
*Counled as sudden cardiac death m actuarial analysis. A = amiodarone; A t W = alive and well; AA = antiarhythmic therapy: Al = arrhythmia induced; 
AICD = automatic implantable cardioverteridefibrillator; Ap = aprindine: B = bretylium; CHF = congestive heart failure: CL = cycle length: CVA = 
cerebrovascular accident: D = disopyramide; E = encainide: EPS = electrophysiologic study; F = flecainide; L = lidocaine: Lo = lorcainide: M = mexiletine; 
op = operative: P = procainamide; Ph = phenytoin; postop = postoperative; Pt = patient; Q = quinidine: S = sotalol: SCD = sudden cardiac death; spont = 
spontaneous: T = tocainide: VT-NS = nonsustained ventricular tachycardia; VT-S = sustained ventricular tachycardia. 
A + w 
A+W 
A + w 
A + w 
A * w 
A-W 
A-W 
A-W 
A -+ W 
Outcome 
Follow- 
UP 
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POSTOPERATIVE EPS (n = 38 1 Table 5. Long-Term Management in 43 Survivors of Surgery 
/ \ 
/ No lnduci ble VT: 14 
1 4 I 
Inducible VF:2 Inducible VT.S: 12 Inducible VT-NS: IO 
EPS on Drug Therapy (n=l8) 
,ll\l...cible VT:II 
Inducible’ VT-S:5 inducible iT-NS: 2 
Figure 1. Results of postoperative electrophysiologic study (EPS) in 
38 patients. VF = ventricular fibrillation; VT = ventricular tachy- 
cardia, sustained (S) or nonsustained (NS). 
pulmonary toxicity confirmed by lung biopsy. Nonfatal 
postoperative complications (four patients) included com- 
plete heart block requiring permanent pacemaker implanta- 
tion in two, cerebrovascular accident in one patient and 
pseudomonas septicemia in one. Of the 21 patients who 
underwent surgery for medically refractory ventricular 
tachycardia within 2 months of myocardial infarction, 2 died 
before hospital discharge. Thus, in this high risk subgroup, 
which had a mean age of 63 years, a mean preoperative left 
ventricular ejection fraction of 25% and a mean left ventric- 
ular end-diastolic pressure of 27 mm Hg, the operative 
mortality rate was 9.5%. 
Postoperative electrophysiologic testing (Table 4, Fig. 1). 
Postoperative electrophysiologic testing was performed in 38 
patients; of these, 24 (63%) had no (14 patients) or only 
nonsustained (10 patients) ventricular tachycardia induced. 
Five patients who had inducible (four patients) or frequent 
spontaneous (one patient) sustained ventricular tachycardia 
while taking amiodarone preoperatively had no inducible or 
only nonsustained ventricular tachycardia postoperatively. 
Triple extrastimulation in the drug-free state induced ven- 
tricular fibrillation in one patient (Patient 6) and sustained 
ventricular tachycardia in two others (Patients 4 and 42). In 
these latter three cases the induced rhythms were so unlike 
the observed clinical forms that they were not taken into 
consideration when organizing the ultimate long-term thera- 
peutic plan. In addition, 13 patients had no inducible (11 
patients) or only nonsustained (2 patients) ventricular tachy- 
cardia when restudied while receiving antiarrhythmic ther- 
apy. Five patients continued to have inducible sustained 
ventricular tachycardia despite further antiarrhythmic drug 
trials. 
No postoperative electrophysiologic testing was per- 
Patients 
Treatment 
No antiarrhythmic therapy 
No. % 
Without AICD device 
With AICD device 
Antiarrhythmic therapy 
18 42 
1 2 
Without AICD device 
With AICD device 
Total 
Abbreviations as in Table 2. 
22 51 
2 5 
43 100 
formed in eight patients because of operative death (three 
patients), postoperative cerebrovascular accident (one 
patient), patient refusal (three patients) and development of 
incessant, slow sustained ventricular tachycardia that was 
suppressed pharmacologically (one patient). 
Postoperative antiarrhythmic treatment (Table 5). Be- 
cause early in our experience the significance of induced 
nonclinical arrhythmias was unclear, antiarrhythmic drugs 
were often included in the long-term management of patients 
who had nonsustained ventricular tachycardia induced dur- 
ing postoperative electrophysiologic testing in a drug-free 
state. Thus, of the 43 patients who survived surgery, 18 
(42%) were ultimately discharged from the hospital receiving 
no long-term antiarrhythmic therapy, whereas antiarrhyth- 
mic drugs were prescribed to 24 (56%). One patient (Patient 
8) who presented clinically with aborted sudden cardiac 
death, and who had ventricular fibrillation induced by triple 
ventricular extrastimulation, received an automatic internal 
cardioverter/defibrillator only. Antiarrhythmic drugs were 
used to suppress induced (10 patients) or spontaneous (1 
patient) sustained ventricular tachycardia and to suppress 
induced nonsustained ventricular tachycardia in 7 patients. 
Five patients who had inducible or frequent spontaneous 
sustained ventricular tachycardia while receiving amioda- 
rone preoperatively and had no inducible or only non- 
sustained ventricular tachycardia on postoperative elec- 
trophysiologic testing continued amiodarone therapy on a 
long-term basis. Finally, antiarrhythmic therapy was admin- 
istered for suppression of high grade and complex ventricu- 
lar ectopic activity in one patient (Patient 5) who refused to 
undergo postoperative testing. This patient died suddenly 2 
months after hospital discharge. 
Of the 24 patients receiving long-term antiarrhythmic 
drug therapy 10 received a single agent other than amioda- 
rone, 1 patient received combination therapy not including 
amiodarone, 3 patients received amiodarone alone, 8 re- 
ceived combination therapy that included amiodarone and 2 
received both amiodarone and an automatic internal cardio- 
verterldefibrillator. 
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Table 6. Outcome of the 46 Patients After an Average Follow-Up 
of 36 Months 
Patients 
NO. !: 
Operative death 3 6.‘; 
Death during t’ollou-up I3 28 
Sudden cardiac dearh x 
Nonsudden cardiac death 3 
Noncardiac death I 
Alive 30 65.5 
Mortality and arrhythmia recurrences (Tables 4 and 6). 
During a mean follow-up period of 36 f 26 months (range 2 
to 88). 13 of the 43 patients died after hospital discharge. 
Eight patients died suddenly. three from relentless, chronic 
heart failure, one patient from myocardial reinfarction and 
one from a noncardiac cause. Figure 2 illustrates the death 
rate, including operative mortality, from all cardiac causes 
and from sudden cardiac death. The overall cumulative 
cardiac mortality rate at I,2 and 3 years was 16,22 and 3%. 
respectively. whereas the mortality rate from sudden cardiac 
death was 5. 12 and 2055, respectively. A separate survival 
analysis was performed for the 21 patients operated on 
within 3 months of myocardial infarction. In this particularly 
high risk group. the overall cardiac mortality rate at I, 2 and 
3 years was 20, 26 and 46%. respectively, whereas the 
mortality rate from sudden cardiac death was 0, 7 and 24%. 
respecti\,ely. 
One patient who had inducible nonsustained ventricular 
tachycardia during postoperative electrophysiologic testing 
and who was discharged on no antiarrhythmic therapy 
Figure 2. Survival and death rate (including operative) in 46 patients. 
Solid line = all patients; dashed line = patients operated on within 2 
months of myocardial infarction. 
I I I I I I I 
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experienced a recurrence of nonhypotensive sustained ven- 
tricular tachycardia that was suppressed with procainamide. 
One other patient, wearing an automatic internal cardio- 
verteridefibrillator and receiving amiodarone. was appropri- 
ately shocked by the device 21 months after surgery in the 
setting of 5evere heart failure, from which he died 2 months 
later. For the purpose of our analysis, this patient was 
classified in the group with sudden cardiac death. 
Long-term functional status. Functional assessment was 
performed of the 42 patients surviving >2 months after 
hospital discharge. Twenty-two patients were fully func- 
tional. 14 were well compensated with therapy, 5 were 
limited by chronic congestive failure and I patient could not 
be evaluated because of cerebrovascular accident. 
Discussion 
In the past IS years our understanding of the mechanisms 
underlying the development and sustenance of ventricular 
tachyarrhythmia due to chronic ischemic heart disease has 
advanced enormously primarily because of the contributions 
of inspired, meticulous and well designed experimental and 
clinical studies. Of particular importance was the recognition 
that in humans, reentry is the most common mechanism 
responsible for sustained ventricular tachyarrhythmia after 
recovery from myocardial infarction ( 17) and that the patho- 
logic substrate containing the critical elements of a reentrant 
pathway is usually situated in subendocardial regions com- 
posed of normal myocardium mixed with fibrotic tissue (18). 
Supported by in vitro and microscopic studies of animal (19) 
and human (20) infarcted tissue, epicardia1 and endocardial 
mapping. combined with programmed stimulation in vivo, 
has been instrumental in characterizing the pathogenesis of 
ventricular tachyarrhythmia in chronic coronary artery dis- 
ease (11-26). 
Surgical techniques. These successful investigative ef- 
forts have led to the development of various surgical tech- 
niques aimed at disabling or eradicating the arrhythmogenic 
terrain. Since 1982 many reports (2.4-16) have described the 
use of surgical procedures as the primary mode of treating 
life-threatening ventricular arrhythmias: most of these have 
included attempts to map the arrhythmia intraoperatively. 
Although the use of intraoperative mapping by highly skilled 
individuals is associated with a low incidence of postopera- 
tive tachycardia inducibility. its overall impact on patient 
long-term survival remains difficult to measure. 
When we began to include surgery as a therapeutic option 
for our patients who had a left ventricular aneurysm, intra- 
operative mapping techniques were in their infancy, and 
nonguided encircling ventriculotomy represented a hopeful 
alternative. As our initial experience grew. it became appar- 
ent that the short-term results were better than those re- 
ported by others using nonguided surgery (2.3) and that our 
systematic strategy was worth pursuing. Whereas postoper- 
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ative inducibility of sustained or nonsustained ventricular 
tachycardia was observed in >50% of our cases, the arrhyth- 
mia was in most cases ultimately suppressed, in some of 
these by previously ineffective drugs. Furthermore, as addi- 
tional information became available from other institutions 
describing the importance of extensive subendocardial scar 
resection (4,5), these procedures were applied to our own 
cases. In the final analysis, a greater percentage of our 
patients, as compared with those in other series, are com- 
mitted to drug therapy, but their long-term survival com- 
pares well with that reported by others (2,5,7,8,10,11,14,16). 
Our experience does not disprove the value of intraoper- 
ative mapping in the treatment of certain patients undergo- 
ing surgical treatment of ventricular arrhythmias. It demon- 
strates, however, that nonguided arrhythmia surgery 
performed systematically in a mix of patients who have left 
ventricular aneurysm is associated with a long-term survival 
equivalent to or better than that reported by users of 
mapping techniques. Because approximately 40% of our 
patients had inducible sustained ventricular tachycarrhyth- 
mias postoperatively, we recommend that the procedure be 
systematically supported by electrophysiologic testing and, 
when necessary, by additional drug therapy. The selection of 
patients in need of long-term postoperative antiarrhythmic 
therapy has been facilitated over the years by a better 
appreciation of the nonspecificity of nonsustained and sus- 
tained polymorphous ventricular arrhythmias induced by 
triple extrastimulation (27,28), unless they resembled the 
forms observed clinically. Thus, whereas vigorous attempts 
were made to suppress induction of all forms of ventricular 
arrhythmias at the beginning of our experience, we now 
restrict our antiarrhythmic efforts postoperatively to the 
suppression of what we recognize as the clinical arrhyth- 
mias, spontaneous or induced preoperatively. 
Role of amiodarone. Because amiodarone was included 
in the long-term drug regimen of 13 of our patients, one 
might argue that it was a major contributor to the reasonably 
low sudden death rate of our patients. However, in seven of 
these patients (five refractory to amiodarone preoperatively) 
a measurable effect of surgery was demonstrated postoper- 
atively in the form of abolition of ventricular tachycardia 
inducibility or induction of nonsustained ventricular tachy- 
cardia only. In addition, the condition of several of our 
patients was so unstable preoperatively that no time could be 
spent in a trial of amiodarone, whereas the operation nearly 
invariably resulted in an impressive clinical stabilization, 
giving us a chance to organize more electively the long-term 
therapeutic regimen. 
Surgery early versus late after myocardial infarction. Per- 
haps the most encouraging part of our study is the low 
operative mortality rate (9.5%) and low sudden death rate 
(0% in the 1 st year) recorded in the group of 21 patients who 
underwent operation within 2 months of acute myocardial 
infarction. These patients were, in general, clinically highly 
unstable from both an arrhythmic and a hemodynamic 
standpoint. The prognosis of such patients, with medical 
management, is known to be dismal (29,30). The gravity of 
their condition is reflected in their preoperative hemody- 
namic measurements as well as in their relatively high 
long-term death rate from all cardiac causes. There is often 
little chance to perform adequate preoperative mapping in 
these patients, and the plurality of their spontaneous or 
induced tachyarrhythmias has been shown to reduce the 
success rate of intraoperative mapping (31,32). Conse- 
quently, patients who undergo operation early after acute 
myocardial infarction often have to be managed with a 
nonguided surgical procedure. Our results suggest that their 
prognosis, from the standpoint of sudden death within the 
first 2 years, can be improved markedly by the use of our 
systematic strategy. Similar results have been reported by 
others using both guided and nonguided surgery (32,33). 
Long-term mortality. If one discounts the operative 
deaths, overall mortality was caused primarily by progres- 
sive congestive heart failure and sudden cardiac death. 
Three of the four patients dying of congestive heart failure 
did so within 2 years after surgery, whereas five of the seven 
patients who died suddenly died between 2 and 5 years 
postoperatively. Although the numbers are small, this differ- 
ence in the pattern of late deaths raises an important issue 
pertinent to long-term management. Whereas little, except 
cardiac transplantation, can be offered at this point to treat 
progressive congestive heart failure in younger patients the 
late reemergence of fatal tachyarrhythmias may be at least 
partially preventable by a more rigorous monitoring of each 
patient surviving beyond the 1st year of follow-up. Both 
noninvasive and invasive methods may be needed to identify 
the individuals who face a return of life-threatening electrical 
instability. 
Limitations of our approach. We recognize distinct limi- 
tations in the approach described by this study: 1) We 
observed a higher rate of postoperative tachyarrhythmia 
inducibility than has been reported in studies using map- 
guided operations; hence, a greater number of our patients 
are committed to long-term antiarrhythmic therapy. 2) This 
approach was only used for patients who had a distinct left 
ventricular aneurysm and may not apply to patients with an 
infarct whose boundaries are ill defined. 3) Because we used 
a variety of surgical techniques in combination, the precise 
contribution of any one of them is unclear, and our study 
does not further our understanding of the mechanisms of 
ventricular tachyarrhythmia in humans. 
Advantages of our approach. We also perceive advan- 
tages in this form of management: 1) It is applicable to 
patients who are critically ill and whose hemodynamic status 
or arrhythmia characteristics preclude preoperative or intra- 
operative mapping. 2) It offers an alternative for institutions 
that do not have the equipment, personnel or expertise to 
perform map-guided surgery, provided, however, that they 
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have experienced surgeons and electrophysiologists. 3) Our 
operative mortality, which included no death from cardiac 
causes, is one of the lowest reported in this type of surgery. 
It may be that an expeditious operation that does not require 
the establishment of a period of normothermic bypass and 
repeated induction of ventricular tachycardiaiventricular fi- 
brillation is responsible for this low operative mortality. 
Conclusions. Our results suggest that, as a result of 
surgical and medical advances in antiarrhythmic therapy, 
high risk patients who undergo nonguided surgery for life- 
threatening ventricular arrhythmia and left ventricular aneu- 
rysm have a relatively low surgical mortality rate, and a 
better survival rate than previously reported. However, if 
utilized, this approach should be systematically supported 
by perioperative electrophysiologic testing to determine the 
need for supplemental antiarrhythmic therapy. Further stud- 
ies are needed to identify the patients who are most likely to 
benefit from intraoperative map-guided surgery. 
We thank Margie Galkowski and Cindy Welch for diligent secretarial a\si\- 
tance and Kenneth B. Schechtman. PhD for bioatatistical support. 
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